Publication:
Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields.

dc.contributor.authorCañete-Sánchez, Francisco M
dc.contributor.authorBoulvard-Chollet, Xavier L E
dc.contributor.authorChamorro, Xabier
dc.contributor.authorMarrodán MArch, Pablo Javier
dc.contributor.authorGarrastachu Zumarán, Puy
dc.contributor.authorRamírez Lasanta, Rafael
dc.contributor.authorColletti, Patrick M
dc.contributor.authorGiammarile, Francesco
dc.contributor.authorDelgado Bolton, Roberto C
dc.date.accessioned2023-05-03T13:28:08Z
dc.date.available2023-05-03T13:28:08Z
dc.date.issued2022-05-19
dc.description.abstractPoint of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead shields that reduce SPI and acquisition time. Two concave lead shields, a semioval lead shield (OLS) and a semispherical lead alloy shield (SLS), were created with a SICNOVA JCR 1000 3D printer to cover the point of injection (patent no. ES1219895U). Twenty breast cancer patients had anterior and anterior oblique imaging, 5 minutes and 2 hours after a single 111 MBq nanocolloid in 0.2 mL intratumoral or periareolar injection. Each acquisition was 2 minutes. Absolute and normalized background corrected scatter counts (CSCs) and scatter reduction percentage (%SR) related to the FLS were calculated. Repositionings were recorded. Differences between means of %SR (t test) and between means of CSC (analysis of variance) with Holm multiple comparison tests were determined. Mean %SR was 91.8% with OLS and 92% using SLS in early images (P = 0.91) and 87.2%SR in OLS and 88.5% in late images (P = 0.66). There were significant differences between CSC using FLS and OLS (P We designed 2 concave lead shields that significantly reduce the SPI and repositioning with sentinel lymph node lymphoscintigraphy.
dc.identifier.doi10.1097/RLU.0000000000004274
dc.identifier.essn1536-0229
dc.identifier.pmcPMC9169747
dc.identifier.pmid35605055
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169747/pdf
dc.identifier.unpaywallURLhttps://journals.lww.com/nuclearmed/Fulltext/2022/07000/Sentinel_Node_Biopsy_Imaging_in_Breast_Cancer_.7.aspx
dc.identifier.urihttp://hdl.handle.net/10668/19867
dc.issue.number7
dc.journal.titleClinical nuclear medicine
dc.journal.titleabbreviationClin Nucl Med
dc.language.isoen
dc.organizationHospital Universitario Puerta del Mar
dc.page.number618-624
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshBreast Neoplasms
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLymph Nodes
dc.subject.meshLymphatic Metastasis
dc.subject.meshRadionuclide Imaging
dc.subject.meshRadiopharmaceuticals
dc.subject.meshSentinel Lymph Node Biopsy
dc.titleSentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number47
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9169747.pdf
Size:
788.88 KB
Format:
Adobe Portable Document Format